RAPT THERAPEUTICS INC's ticker is RAPT and the CUSIP is 75382E109. A total of 88 filers reported holding RAPT THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.25 and the average weighting 1.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $10,453,347 | +2.8% | 628,886 | +15.6% | 0.00% | 0.0% |
Q2 2023 | $10,171,871 | +4.9% | 543,950 | +2.9% | 0.00% | 0.0% |
Q1 2023 | $9,698,990 | +107582.8% | 528,555 | +16.2% | 0.00% | 0.0% |
Q4 2022 | $9,007 | -99.9% | 454,906 | +7.0% | 0.00% | -50.0% |
Q3 2022 | $10,228,000 | +37.9% | 425,143 | +4.6% | 0.00% | +100.0% |
Q2 2022 | $7,417,000 | -9.0% | 406,432 | +9.7% | 0.00% | 0.0% |
Q1 2022 | $8,149,000 | -35.5% | 370,591 | +7.7% | 0.00% | -50.0% |
Q4 2021 | $12,635,000 | +17.3% | 344,014 | -0.8% | 0.00% | +100.0% |
Q3 2021 | $10,770,000 | +48.9% | 346,867 | +52.4% | 0.00% | 0.0% |
Q2 2021 | $7,235,000 | +92.3% | 227,588 | +34.3% | 0.00% | 0.0% |
Q1 2021 | $3,763,000 | +32.4% | 169,513 | +17.7% | 0.00% | – |
Q4 2020 | $2,843,000 | -35.9% | 143,975 | +4.4% | 0.00% | -100.0% |
Q3 2020 | $4,438,000 | +16.4% | 137,844 | +4.9% | 0.00% | 0.0% |
Q2 2020 | $3,813,000 | +154.2% | 131,396 | +86.2% | 0.00% | – |
Q1 2020 | $1,500,000 | -8.1% | 70,552 | +19.2% | 0.00% | – |
Q4 2019 | $1,632,000 | – | 59,172 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Ponoi Management, LLC | 1,599,417 | $29,189,000 | 46.08% |
KPCB XV Associates, LLC | 1,297,063 | $23,671,000 | 43.66% |
Column Group LLC | 2,680,458 | $48,918,000 | 10.41% |
Ponoi II Management, LLC | 145,401 | $2,654,000 | 7.21% |
Euclidean Capital LLC | 432,900 | $7,900,000 | 6.72% |
AJU IB Investment Co., Ltd. | 99,503 | $1,816,000 | 3.52% |
KINGDON CAPITAL MANAGEMENT, L.L.C. | 1,023,321 | $18,676,000 | 3.17% |
REGENTS OF THE UNIVERSITY OF CALIFORNIA | 443,619 | $8,096,000 | 1.62% |
Ghost Tree Capital, LLC | 165,000 | $3,011,000 | 1.57% |
Perceptive Advisors | 1,913,791 | $34,927,000 | 1.09% |